These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33549310)

  • 1. A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19.
    Chalkias A; Barreto EF; Laou E; Kolonia K; Scheetz MH; Gourgoulianis K; Pantazopoulos I; Xanthos T
    Clin Ther; 2021 Mar; 43(3):e57-e70. PubMed ID: 33549310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.
    Zhang Y; Chen Y; Meng Z
    Front Immunol; 2020; 11():577442. PubMed ID: 33240265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune system and COVID-19: Friend or foe?
    Yazdanpanah F; Hamblin MR; Rezaei N
    Life Sci; 2020 Sep; 256():117900. PubMed ID: 32502542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.
    Fang XZ; Wang YX; Xu JQ; He YJ; Peng ZK; Shang Y
    Front Immunol; 2021; 12():651545. PubMed ID: 34149692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS.
    Notz Q; Herrmann J; Schlesinger T; Helmer P; Sudowe S; Sun Q; Hackler J; Roeder D; Lotz C; Meybohm P; Kranke P; Schomburg L; Stoppe C
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).
    Ma X; Liang M; Ding M; Liu W; Ma H; Zhou X; Ren H
    Med Sci Monit; 2020 Aug; 26():e925364. PubMed ID: 32759887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.
    Alser O; Mokhtari A; Naar L; Langeveld K; Breen KA; El Moheb M; Kapoen C; Gaitanidis A; Christensen MA; Maurer LR; Mashbari H; Bankhead-Kendall B; Parks J; Fawley J; Saillant N; Mendoza A; Paranjape C; Fagenholz P; King D; Lee J; Farhat MR; Velmahos GC; Kaafarani HMA
    J Trauma Acute Care Surg; 2021 May; 90(5):880-890. PubMed ID: 33891572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
    Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
    Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible therapeutic effects of
    Khazdair MR; Ghafari S; Sadeghi M
    Pharm Biol; 2021 Dec; 59(1):696-703. PubMed ID: 34110959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal replacement therapy for critically ill patients with COVID-19-associated acute kidney injury: A review of current knowledge.
    Shemies RS; Nagy E; Younis D; Sheashaa H
    Ther Apher Dial; 2022 Feb; 26(1):15-23. PubMed ID: 34378870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19.
    Albtoush N; Petrey AC
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1037-C1046. PubMed ID: 35442830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygenation Strategies in Critically Ill Patients With COVID-19.
    Evers JM; Pehlke SJ; Jones LL; Urquhart MG
    Dimens Crit Care Nurs; 2021 Mar-Apr 01; 40(2):75-82. PubMed ID: 33961375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review.
    Grasselli G; Cattaneo E; Florio G; Ippolito M; Zanella A; Cortegiani A; Huang J; Pesenti A; Einav S
    Crit Care; 2021 Mar; 25(1):115. PubMed ID: 33743812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids.
    Brugiere O; Neuville M; Le Balch P; Le Tulzo Y; Brun AL; Hamid A; Beaumont L; Roux A; Jouneau S; Parquin F
    Exp Clin Transplant; 2021 Jul; 19(7):744-748. PubMed ID: 34085913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome.
    Adam EH; Schmid B; Sonntagbauer M; Kranke P; Zacharowski K; Meybohm P
    Crit Care; 2020 Sep; 24(1):574. PubMed ID: 32972429
    [No Abstract]   [Full Text] [Related]  

  • 17. An update: the emerging evidence of complement involvement in COVID-19.
    Li Q; Chen Z
    Med Microbiol Immunol; 2021 Jun; 210(2-3):101-109. PubMed ID: 33811541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
    Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
    J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
    Choudhury R; Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Talmor DS; Nydam TL; Yaffe MB
    World J Emerg Surg; 2020 Apr; 15(1):29. PubMed ID: 32312290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.